NASDAQ · Healthcare · Medical - Pharmaceuticals
Avalyn Pharma Inc. Common Stock
AVLN
Avalyn Pharma, Inc. CEO Lyn Baranowski · Market cap $1.2B.
$29.57
+2.24 · +8.20%
52w hi $30.6752w lo $25.05
Off 52w high 10.6%
66
NOTABLE
Current InsiderScore
Corp · 90d
4
4 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
3
0 strong · 3 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
4 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 01 | SR ONE CAPITAL MANAGEMENT, LLC | Buy | 277,777 | $18.00 | +$5.00M | 66 | |
| May 01 | SR ONE CAPITAL MANAGEMENT, LLC | Buy | 277,778 | $18.00 | +$5.00M | 65 | |
| May 01 | Jill Carroll | Buy | 277,778 | $18.00 | +$5.00M | 61 | |
| May 01 | Novo Holdings A/S | Buy | 555,555 | $18.00 | +$10.00M | 59 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay